media – Page 574 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Four health systems and VA plan to create nonprofit drug company

Four health systems — Intermountain Healthcare, Ascension, SSM Health and Trinity Health — and the U.S. Department of Veterans Affairs will launch a nonprofit generic drug company.
- Source: Medcitynews
- 421
- March 7, 2018
generic drug Market Views
First European filing acceptance of a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor in type-1 diabetes

AstraZeneca today announced that the European Medicines Agency has accepted the Marketing Authorisation Variation forForxiga (dapagliflozin), a selective SGLT-2 inhibitor, for use as an oral adjunct treatment to insulin in adults with type-1 diabetes (T1D).
- Source: astrazeneca
- 681
- March 7, 2018
AstraZeneca diabetes Forxiga insulin New Approvals
Vividion Therapeutics Announces Strategic Research Collaboration with Celgene Corporation to Discover Therapies Against Transformative, First-in-Class Targets

Vividion to receive $101 million in upfront payment, including equity investment Collaboration utilizes Vividion's unique proteome-wide ligand and target discovery platform
- Source: prnewswire
- 462
- March 7, 2018
Celgene
Market for 3D-printed medical devices to cross $2 bn by 2025

The global market for 3D printing of medical devices is estimated to touch $2.77 billion by 2015, according to a new study by market research and investment information firm Profshare Market Research.
- Source: TechCircle
- 412
- March 7, 2018
3D printing Market Views medical device products
New wearable may hold benefits for people with Parkinson’s

A new prototype for wearable tremor suppression gloves has a team of Western University researchers believing real change is on the way for the more than 6 million people in the world afflicted by Parkinson's disease. For more information see the IDTechEx report on wearable technology.
- Source: 3D Printing Progress
- 623
- March 7, 2018
medical device Parkinson's Researches
Global health startup PharmaJet with needle-free injectable device close to raising $5M

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.
- Source: MedCityNews
- 1,051
- March 7, 2018
Company Insight medical device products WHO
TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer

TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with Genentech, a member of the Roche Group, to evaluate the combination of the PD-L1 antibody atezolizumab (TECENTRIQ®) and TESARO’s PARP-inhibitor ZEJULA® (niraparib) in patients with metastatic bladder cancer.
- Source: ir.tesarobio
- 799
- March 6, 2018
antibody bladder cancer Market Views oncology
Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million

Finch Therapeutics, headquartered in Somerville, Massachusetts, closed on an oversubscribed Series B financing worth $36 million. Since the company’s launch, it has raised $77 million. Series B investors included Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital.
- Source: Biospace
- 576
- March 6, 2018
Market Views microbiome Series
The right amount of vitamin D can reduce mortality risk says new study

A new Norwegian study suggests that getting the right amount of vitamin D could substantially reduce an individual's risk of death.
- Source: msn
- 654
- March 6, 2018
cardiovascular diseases Researches vitamin D
Sanofi files Dupixent for severe asthma

US regulators have accepted for review Sanofi/Regeneron’s biologic Dupixent as an add-on maintenance treatment in certain adults and adolescents with moderate-to-severe asthma.
- Source: pharmatimes
- 1,000
- March 6, 2018
asthma Dupixent New Approvals Sanofi

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.